HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women [Phase 2, Phase 3]
A clinical trial testing safer-sex skill-building to reduce HIV risk in pregnant women with substance use issues has completed Phase 2 and P…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of TBC-M4, an MVA-based HIV vaccine, administered alone or in a prime-boost regimen w…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of an MVA-based HIV vaccine in HIV-uninfected adults; study completed.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Immunogenicity Study of 2 Investigational Preventive HIV Vaccines [Phase 1]
The report summarizes safety and immunogenicity findings from a Phase 1 study of two investigational preventive HIV vaccines.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
A completed clinical trial from Milan evaluated the efficacy of raltegravir in a large urban HIV patient population.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults [Phase 1]
Phase 1 trial evaluating the safety and immunogenicity of a plasmid HIV vaccine in HIV-uninfected adults.
-
CLINICAL_TRIALS research · 2013-02-11Clinical Trial Update: GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
A clinical trial update examining genotypic and phenotypic methods to diagnose HIV-1 resistance to raltegravir by parallel analysis of resis…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
A study evaluating an antiretroviral-sparing concept using HIV-specific T cell precursors with high proliferative capacity (PHPC) has comple…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Role of HIV on Glutathione Synthesis and Oxidative Stress [Phase 1]
Phase 1 clinical trial investigating whether HIV infection affects glutathione synthesis and oxidative stress in erythrocytes.
-
FDA approval · 2013-02-04FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for NEVIRAPINE from Aurobindo Pharma Limited, authorizing an additional regulatory action on this ge…
-
FDA approval · 2013-02-01FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP. The approval updates the product's la…
-
FDA approval · 2013-02-01FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company. The action updates or expands th…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1 [Phase 2]
A Phase 2 study evaluated the impact of an integrase inhibitor on HIV-1 latency and the viral reservoir; the trial status is completed.
-
FDA approval · 2013-02-01FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nevirapine from Aurobindo Pharma Limited under an ANDA, confirming regulatory approval of a gene…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Preliminary Evaluation of a Point-Of-Care Liver Function Test [NA]
This completed clinical trial evaluates a point-of-care liver function test for detecting drug-induced liver injury in individuals with HIV …
-
FDA approval · 2013-01-30FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C. The approval concerns HIV infec…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV [Phase 2]
An update on a Phase II trial of the immunotherapy AGS-004 in ART-treated HIV-infected subjects, noting the study status as completed.
-
FDA approval · 2013-01-25FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) filed…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Folinic Acid and Vascular Reactivity in HIV [NA]
A completed clinical trial evaluating folinic acid and vascular reactivity in people with HIV infection.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects [Phase 4]
This Phase 4 trial evaluated switching HIV patients from an NNRTI or protease inhibitor to maraviroc; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: HIV Screening in the Emergency Department Setting [NA]
This clinical trial update notes the completion of an HIV screening study conducted in emergency department settings and that its results we…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine [Phase 3]
Phase 3 trial comparing cotrimoxazole prophylaxis to mefloquine for preventing malaria during pregnancy in HIV-infected women; the study has…
-
FDA approval · 2013-01-17FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) from AbbVie Inc.
-
FDA approval · 2013-01-17FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approves a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie, updating labeling.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania [Phase 4]
Phase 4 clinical trial evaluating interactions between artemether-lumefantrine and antiretrovirals in HIV-infected patients with uncomplicat…